{
  "ticker": "OCC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964876",
  "id": "02964876",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250702",
  "time": "0903",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250702/pdf/06lcg19zjw5586.pdf",
  "summary": "**Summary of ASX Announcement:**  \n\n- **Appointment of Key Executives**:  \n  - Jim Piper appointed as **Chief Financial Officer (CFO)**, effective 1 August 2025.  \n  - Adam Wood appointed as **Chief Commercial Officer (CCO)** to lead global sales and marketing (focus: US expansion).  \n- **Strategic Rationale**: Positions Orthocell for **revenue growth** and **global commercialization** of Remplir\u2122 (nerve repair device), targeting a **US$3.5B+ addressable market**.  \n\n**No material trading or capital markets impact identified** (no capital raising, financial data, or material operational updates provided).",
  "usage": {
    "prompt_tokens": 2125,
    "completion_tokens": 142,
    "total_tokens": 2267,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-01T23:19:39.272099"
}